Structural Heart Devices Market Outlook, Competitive Insights, and Growth Factors during the Forecast Period 2022-2028

 

Structural Heart Devices Market

Congenital (present at birth) cardiac anomalies are referred to as structural heart illnesses, along with abnormalities that develop in the heart's valves and arteries as a result of disease-related wear and tear. A non-coronary disorder of the heart, structural heart disease has no effect on the heart's blood arteries. Atrial septal defect, patent foramen oval, ventricular septal defect, paravalvular leak, arterial/venous fistulae, and congenital heart disease are among the most common structural heart conditions.

Due to ongoing efforts to develop novel products and subsequent product releases by major key players based in the area, North America is anticipated to have a prominent position in the global Structural Heart Devices Market. For instance, the American company Edwards Lifesciences Corporation is concentrating on the launch of the SAPIEN 3 Ultra and CENTERA Valves in 2017. The SAPIEN 3 Ultra system is a cutting-edge platform with an on-balloon delivery design and extensible Axela sheath technology. This innovative invention should speed up the manufacturing processes while reducing error-proneness.

Additionally, because to the rising incidence of valvular heart disease (VHD) throughout the continent, structural heart devices are predicted to experience significant increase in Europe. Incidence of VHD was 63.9 per 100 000 person-years, with aortic stenosis (AS) accounting for 47.2% of cases, mitral regurgitation (MR) for 24.2%, and aortic regurgitation (AR) for 18.0%, according to a study published in the British Medical Journal (BMJ) in 2017. To arrive at this result, the study examined hospital data collected nationally between 2003 and 2010.

Modern items, such sutureless heart valves, are substantially more expensive than earlier models. For instance, LivaNova, Plcsuture-free .'s aortic heart valve costs more than US$ 9,000, but tissue heart valves made by Medtronic Plc. and Abbott Laboratories cost about US$ 5,000 in the United States. The use of sutureless technology has been constrained by its nearly twofold price, which is also slowing the Structural Heart Devices Market expansion.

Key players in Global Structural Heart Devices Market include Abbott Laboratories, Medtronic Plc., Edwards Lifesciences Corporation, Boston Scientific Corporation, CryoLife Inc., LivaNova Plc., Cook Group Incorporated, Endologix Inc., and W. L. Gore & Associates, Inc. 

Comments

Post a Comment

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

Image
Security Robot Market The Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period of 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Security Robot Market encompasses advanced robotic technologies that are specifically designed and developed to enhance security and surveillance operations. These robots are equipped with features such as video surveillance, thermal imaging, facial recognition, and intrusion detection, among others. They are extensively used by security agencies and organizations across various sectors, including residential, commercial, industrial, and government, to enhance safety, reduce human intervention, and streamline security operations. Security robots offer real-time monitoring, remote control, and high accuracy, making them an ideal choice for surveillance in sensitive areas and remote locations. Market Dynamics:
Read more

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Image
  Scottish Whisky Market The Scottish Whisky Market is a captivating landscape that has been evolving and transforming over the years. It is a world of tradition, craftsmanship, and heritage, where every drop of whisky tells a story. The history of Scottish whisky traces back centuries, with the earliest records dating back to the 15th century. Whisky production initially started in monasteries, where monks distilled spirits for medicinal purposes. Over time, whisky production moved from monastic settings to farms and then to commercial distilleries. This transition marked the beginning of an industry that would become synonymous with Scotland. Scottish Whisky Market Was Valued At US$ 4.97 Bn In 2018, And It Is Expected To Reach US$ 7.89 Bn By The End Of 2027, Exhibiting A CAGR Of 5.3% During The Forecast Period (2019 To 2027). One of the defining characteristics of the Scottish Whisky Market is its adherence to traditional production methods. Scotch whisky is made from malted b
Read more

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides

Image
Monochloroacetic Acid (MCAA) Market The Monochloroacetic Acid (MCAA) Market is estimated to be valued at USD 676.52 Million in 2022 and is expected to exhibit a CAGR of 7.03% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Monochloroacetic Acid (MCAA) Market is driven by the increasing demand for surfactants and herbicides in several industries such as agriculture, pharmaceuticals, textiles, and personal care. MCAA is extensively used in the production of surfactants, herbicides, and carboxymethyl cellulose (CMC), which are essential in various applications. These applications include detergents, agrochemicals, pharmaceuticals, dyes, and cosmetics, among others. The versatile properties of MCAA, such as its ability to act as a raw material in the production of herbicides and surfactants, make it highly desirable in the market. Market Dynamics: The Monochloroacetic Acid (MCAA) Market is driven by two k
Read more